Connect Biopharma is a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research.
With operations and expertise in China, the United States and Australia and clinical development activities in those geographies as well as Europe, Connect Biopharma is building a rich pipeline of internally designed, wholly owned small molecules and antibodies targeting several aspects of T cell biology. Our core expertise is in the use of functional cellular assays with T cells to screen and discover potent drug candidates against immune targets. Our two most advanced clinical-stage programs include potentially differentiated product candidates against validated targets.
June 1, 2023
April 11, 2023
March 18, 2023
February 15, 2023 at 4:20 PM EST
January 9, 2023
November 29, 2022 at 9:00 AM EST
- Today's Open
- Previous Close
Data Provided by Refinitiv. Minimum 15 minutes delayed.